المؤلفون: Pascale Exer, Rudolf O. Kissling, Ulrich Weber, Beat A. Michel, Peter M. Villiger, Martin Toniolo, Almut Scherer, Adrian Ciurea, Jürg Bernhard, Pascal Zufferey, Daniel J. Stekhoven, Giorgio Tamborrini

المساهمون: University of Zurich, Ciurea, Adrian

المصدر: Ciurea, A, Weber, U, Stekhoven, D, Scherer, A, Tamborrini, G, Bernhard, J, Toniolo, M, Villiger, P M, Zufferey, P, Kissling, R O, Michel, B A & Exer, P 2015, ' Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis : Comparison between private rheumatology practices and academic centers in a large observational cohort ', Journal of Rheumatology, vol. 42, no. 1, pp. 101-105 . https://doi.org/10.3899/jrheum.140229

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, 2745 Rheumatology, Immunology, Private Practice, 610 Medicine & health, Antirheumatic Agents/therapeutic use, Rheumatology, Internal medicine, Spondylarthritis, Humans, Immunology and Allergy, Medicine, Practice Patterns, Physicians', Axial spondyloarthritis, BASDAI, Spondylarthritis/drug therapy, 2403 Immunology, Academic Medical Centers, Ankylosing spondylitis, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Tumor Necrosis Factor-alpha, business.industry, 10051 Rheumatology Clinic and Institute of Physical Medicine, Middle Aged, medicine.disease, University hospital, adult ankylosing spondylitis Ankylosing Spondylitis Disease Activity Score article cohort analysis *comparative study controlled study female follow up functional assessment human major clinical study male middle aged observational study *private hospital *spondylarthritis/dt [Drug Therapy] treatment indication treatment outcome treatment response *university hospital disease modifying antirheumatic drug/dt [Drug Therapy] nonsteroid antiinflammatory agent/dt [Drug Therapy] *tumor necrosis factor inhibitor/dt [Drug Therapy], Treatment Outcome, Antirheumatic Agents, Cohort, 2723 Immunology and Allergy, Physical therapy, 10046 Balgrist University Hospital, Swiss Spinal Cord Injury Center, Female, Tumor necrosis factor alpha, Observational study, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb400ecdefcf2a6b238cc093810195c8
https://doi.org/10.3899/jrheum.140229

المؤلفون: Raphael Micheroli, Monika Hebeisen, Lukas M. Wildi, Pascale Exer, Giorgio Tamborrini, Jürg Bernhard, Burkhard Möller, Pascal Zufferey, Michael J. Nissen, Almut Scherer, Adrian Ciurea, on behalf of the Rheumatologists of the Swiss Clinical Quality Management Program

المساهمون: University of Zurich, Ciurea, Adrian, Rheumatologists of the Swiss Clinical Quality Management Program

المصدر: Arthritis Research and Therapy, Vol. 19, No 1 (2017) P. 164
Micheroli, Raphael; Hebeisen, Monika; Wildi, Lukas M.; Exer, Pascale; Tamborrini, Giorgio; Bernhard, Jürg; Möller, Burkhard; Zufferey, Pascal; Nissen, Michael J.; Scherer, Almut; Ciurea, Adrian (2017). Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis. Arthritis research & therapy, 19(1), p. 164. BioMed Central 10.1186/s13075-017-1372-3 <http://dx.doi.org/10.1186/s13075-017-1372-3>
Arthritis research & therapy, vol. 19, no. 1, pp. 164
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-8 (2017)

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, medicine.medical_specialty, lcsh:Diseases of the musculoskeletal system, 2745 Rheumatology, Anti-Inflammatory Agents, TNF inhibition, Physical exercise, 610 Medicine & health, Overweight, Anti-Inflammatory Agents/therapeutic use, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Female, Humans, Obesity/complications, Spondylarthritis/drug therapy, Treatment Outcome, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Ankylosing spondylitis, Axial spondyloarthritis, Obesity, Internal medicine, Spondylarthritis, medicine, BASDAI, 030203 arthritis & rheumatology, ddc:616, 2403 Immunology, business.industry, Tumor Necrosis Factor-alpha, 10051 Rheumatology Clinic and Institute of Physical Medicine, Odds ratio, medicine.disease, Confidence interval, 030104 developmental biology, Physical therapy, 2723 Immunology and Allergy, medicine.symptom, lcsh:RC925-935, business, Body mass index, Cohort study, Research Article

وصف الملف: s13075-017-1372-3.pdf - application/pdf; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74aa984ceeab30b8574e9ac784bd0ca4
https://www.zora.uzh.ch/id/eprint/139272/